ID: ALA5183966

Max Phase: Preclinical

Molecular Formula: C24H19N7O2

Molecular Weight: 437.46

Associated Items:

Representations

Canonical SMILES:  N#Cc1ccc2nc(Cc3nc4c(c(=O)[nH]c(=O)n4C4CC4)n3Cc3ccccc3)[nH]c2c1

Standard InChI:  InChI=1S/C24H19N7O2/c25-12-15-6-9-17-18(10-15)27-19(26-17)11-20-28-22-21(30(20)13-14-4-2-1-3-5-14)23(32)29-24(33)31(22)16-7-8-16/h1-6,9-10,16H,7-8,11,13H2,(H,26,27)(H,29,32,33)

Standard InChI Key:  NVASULWOVJHINL-UHFFFAOYSA-N

Associated Targets(Human)

Tryptophan 5-hydroxylase 1 286 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Tryptophan 5-hydroxylase 2 43 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 437.46Molecular Weight (Monoisotopic): 437.1600AlogP: 2.61#Rotatable Bonds: 5
Polar Surface Area: 125.15Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: 0HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.23CX Basic pKa: 5.32CX LogP: 2.90CX LogD: 2.89
Aromatic Rings: 5Heavy Atoms: 33QED Weighted: 0.44Np Likeness Score: -1.67

References

1. Specker E, Matthes S, Wesolowski R, Schütz A, Grohmann M, Alenina N, Pleimes D, Mallow K, Neuenschwander M, Gogolin A, Weise M, Pfeifer J, Ziebart N, Heinemann U, von Kries JP, Nazaré M, Bader M..  (2022)  Structure-Based Design of Xanthine-Benzimidazole Derivatives as Novel and Potent Tryptophan Hydroxylase Inhibitors.,  65  (16.0): [PMID:35921615] [10.1021/acs.jmedchem.2c00598]

Source